Organization
Autifony Therapeutics
1 clinical trial
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Crossover Study of the Effects of Single Doses of AUT00201 in Patients With Myoclonus Epilepsy and Ataxia Due to Potassium (K+) Channel Mutation (MEAK)Status: Completed, Estimated PCD: 2024-05-01